title: Subacute methotrexate-related leukoencephalopathy with stroke-like presentation.
authors.affiliation: Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Hospital, Okayama, Japan.
authors.forename: Kayoko
authors.initials: K
authors.lastname: Iwatani
authors.forename: Nobuharu
authors.initials: N
authors.lastname: Fujii
authors.forename: Shoko
authors.initials: S
authors.lastname: Deguchi
authors.forename: Mitsune
authors.initials: M
authors.lastname: Tanimoto
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D002545:Brain Ischemia / Q000175:diagnosis; D003561:Cytarabine / Q000008:administration & dosage; D003680:Deglutition Disorders / Q000139:chemically induced; D003937:Diagnosis, Differential; D038524:Diffusion Magnetic Resonance Imaging; D004317:Doxorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives; D004401:Dysarthria / Q000139:chemically induced; D006429:Hemiplegia / Q000139:chemically induced; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage; D007267:Injections; D056784:Leukoencephalopathies / Q000139:chemically induced* / Q000175:diagnosis; D018810:Magnetic Resonance Angiography; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects*; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy; D055815:Young Adult
chemical_list: D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine; D004317:Doxorubicin; C027260:pirarubicin; D015122:Mercaptopurine; D006854:Hydrocortisone; D008727:Methotrexate